Table 5.
Form | Construct(s) | Crystallization Conditions * | Space Group | Unit Cell (a, >b, c, Å) | Res. (Å) N † | Notes |
I | MK2(41–364) & MK2(47–366) surface mutants ‡ | AS, LS, & NP pH 5–8 |
N.D. | N.D. | >11 N.D. |
Rods; high mosaicity |
II | MK2(41–364) & MK2(47–366) surface mutants ‡ | AS, LS, & NM pH 5–8 |
N.D. | N.D. | >11 N.D. |
Plates; high mosaicity |
III | MK2(47–366) | 2 M AS 0.1 M Na citrate pH 5.0 4% 1,4-butanediol |
P213 | 215 | 3.4 4 |
Cubes |
IV | MK2(47–366, T222E) | 2 M NM pH 5.5 10 μM Anapoe 80 |
F4132 | 254 | 2.9 1 |
Bipyramids; inhibitor soaking req'd |
V | MK2(41–364) | 1.5–1.8 M NM pH 8.0 |
P63 | 158 158 138 |
2.6–3.3 4 |
Hex. bullets; co-crystals |
VI | MK2(41–364) | 1.5–1.8 M NM pH 8.0 |
P63 | 144 144 152 |
2.6–3.3 4 |
Hex. bullets; co-crystals; "collapsed" Form V |
VII | MK2(41–364) | 1.75 M AS 0.1 M Na citrate pH 8.0 |
P212121 | 140 180 215 |
2.6–3.3 12 |
Sharp blocks; co-crystals |
* AS – (NH4)2SO4; LS – Li2SO4; NM – sodium malonate; NP – sodium phosphate.
† Resolution of diffraction. N – MK2 molecules/crystallographic asymmetric unit.
‡ Constructs 23, 24, 26, 27, 29, 32, 33, 35, and 36 (Form I), and 9, 24, and 33 (Form II) in Additional File 1 Table S7.